Sobre la Empresa
- Nombre legal: Suzhou Origin Specialty Chemicals Co., Ltd.
- Nombre internacional: Suzhou Origin Specialty Chemicals Co., Ltd., Suzhou, Jiangsu, China
- Marca / Nombre comercial: Origin
- País de registro: China
- Dirección: Jiangsu
Descripción:
Suzhou Origin Specialty Chemicals Co., Ltd., founded in 2020, is a manufacturer and service provider focused on custom synthesis of complex fine chemicals and active pharmaceutical ingredient building blocks, spanning chiral phosphine ligands and ruthenium/palladium/nickel catalysts, tetraazacyclododecane (DOTA-type) chelating agents, fluorinated pyrrolidine and piperidine intermediates, and porphyrin derivatives. The company provides CRO, CMO, and CDMO contract services with both ODM and own-brand R&D capability, positioning itself around an experienced R&D staff, contract manufacturing flexibility, and a willingness to accept buyers' specifications and small orders for customers across North America, Western Europe, Australasia, Asia, the Middle East, Central/South America, Eastern Europe, and Africa.
Actividades Comerciales
Pharma Chemicals
ProveedorFabricante de Productos Químicos Especializados
Productos químicos, solventes y estándares de referencia de laboratorio
Proveedor de Síntesis a Medida
Active Pharmaceutical Ingredients (APIs)
FabricanteProveedor de Servicios
Mercados de Venta
- Western Asia: Cyprus
- Northern Europe: Denmark, Finland, Iceland, Ireland, Norway, Sweden, United Kingdom
- Southern Europe: Andorra, Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain
- Western Europe: Austria, Belgium, France, Germany, Liechtenstein, Luxembourg, Monaco, Netherlands, Switzerland
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
Productos/Servicios Clave
- Active Pharmaceutical Ingredients (APIs): DOTA, Cyclen, (3R)-Hexahydro-3-methyl-1H-1,4-diazepine-1-carboxylic acid tert-butyl ester, rel-1,1-Dimethylethyl (2R,3R)-2-cyano-3-hydroxy-1-pyrrolidinecarboxylate, (S)-(-)-2,2'-Bis[di(3,5-xylyl)phosphino]-6,6'-dimethoxy-1,1'-biphenyl, 1,4-BIS(2-HYDROXYHEXAFLUOROISOPROPYL)BENZENE, (S)-1,1'-binaphthalene-2,2'-diylbis(diphenylphosphine oxide), (-)-1,2-BIS((2R,5R)-2,5-DIETHYLPHOSPHOLANO)BENZENE, (+/-)-2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl, 1-(1,1-Dimethylethyl) 2-methyl (2S,3R)-3-fluoro-1,2-pyrrolidinedicarboxylate, 1-(2-diphenylphosphanylnaphthalen-1-yl)naphthalen-2-yl]-diphenylphosphane, 1-(tert-butyl) 2-methyl (2R,3R)-3-hydroxypyrrolidine-1,2-dicarboxylate, 1,1'-Bis{1-[(R)-ferrocenyl-2-(S)-ethyl-1-(diethylamino)phenyl]-(R)-phosphino}ferrocene, 1,1'-Bis[bis(1,1-dimethylethyl)phosphino]ferrocene, 1,1'-Bis(di-tert-butylphosphino)ferrocene-palladium dichloride, 1,1-Dimethylethyl (1R,6S)-3,10-diazabicyclo[4.3.1]decane-3-carboxylate, 1,1-Dimethylethyl (1R,6S)-8-oxa-3,10-diazabicyclo[4.3.1]decane-3-carboxylate, 1,1-Dimethylethyl (2R,3R)-2-cyano-3-hydroxy-1-pyrrolidinecarboxylate, 1,1-Dimethylethyl (2S,3R)-2-(aminocarbonyl)-3-hydroxy-1-pyrrolidinecarboxylate, 1,1-Dimethylethyl 8-oxa-3,10-diazabicyclo[4.3.1]decane-10-carboxylate, 1,2,3,4-TETRAMETHYL-1,3-CYCLOPENTADIENE, 1,3-BIS(2,4,6-TRIMETHYLPHENYL)-IMIDAZOLIDINIUM-CHLORIDE, 1,3-BIS(2,4,6-TRIMETHYLPHENYL)IMIDAZOLIUM CHLORIDE, 1,3-BIS(2,6-DIISOPROPYLPHENYL)-IMIDAZOLIDINIUM-CHLORIDE, 1,3-BIS(2,6-DIISOPROPYLPHENYL)IMIDAZOLIUM CHLORIDE, 1,4-Naphthoquinone, 1,4,7-tri-Boc-1,4,7,10-Tetraazacyclododecane, 1,4,7,10-Tetraazacyclododecan-1-ylacetic acid, 1,4,7,10-Tetraazacyclododecane-1,4-diacetic acid, 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, Mono(1-Methylethyl) ester, 1,4,7,10-Tetraazacyclododecane-1,7-diacetic acid, bis(phenylmethyl) ester, 1,4,7,10-Tetraazacyclododecane-1,7-diacetic Acid, 1,5-Diphenylpenta-1,4-dien-3-one, 1,7-bis-(tert-Butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane, (1R)-1-AMINOINDANE-5-CARBONITRILE HYDROCHLORIDE, (1R,2R)-(-)-N-p-Tosyl-1,2-diphenylethylenediamine, (1Z,5Z)-cycloocta-1,5-diene, 2-(1H-Pyrazol-3-yl)propan-2-ol, 2-Bromo-4-fluoroaniline, 2-(bromomethyl)-3,3-dimethylbut-1-ene, 2-(Dicyclohexylphosphino)-2',4',6'-tri-i-propyl-1,1'-biphenyl, 2-Dicyclohexylphosphino-2',6'-bis(diMethylaMino)-1,1'-biphenyl, 2-Dicyclohexylphosphino-2',6'-dimethoxybiphenyl, 2-(Methylsulfonyl)nicotinaldehyde, 2-(Trifluoromethoxyl)ethanol, 2,2,2-Trifluoro-1-(2-hydroxyphenyl)ethan-1-one, 2,6-Bis(diMethylaMino)-2'-broMo-1,1'-biphenyl, (2R,3S)-3-Hydroxy-2-pyrrolidinecarboxamide, (2S)-4,4-difluoro-1-methylpyrrolidin-2-yl]methanol, (2s, 4r)-boc-gamma-mso-proline methyl ester, (2S,3R)-1-tert-Butyl-2-methyl-3-hydroxypyrrolidine-1,2-dicarboxylate, (2S,3R)-3-Hydroxy-2-pyrrolidinecarboxamide, (2S,4R)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethy, (2S,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxyli, (2S,4S)-1-tert-Butyl 2-methyl 4-(benzoyloxy)pyrrolidine-1,2-dicarboxylate, (2S,4S)-Tert-Butyl2-cyano-4-fluoropyrrolidine-1-carboxylate, 3-Oxa-8-azabicyclo[3.2.1]octane, 3-oxa-9-azabicyclo[3.3.1]nonane, 3,3'-((2-(((benzyloxy)carbonyl)amino)-2-((2-carboxyethoxy)methyl)propane-1,3-diyl)bis(oxy))dipropano, 3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propanenitrile, (3,4,4-trifluoro-3-butenyl) acetate, 3,5-Dimethylpyrazole, 3,5-Dimethylpyrazole-potassium salt, 3,7-Dioxa-9-azabicyclo[3.3.1]nonane, (3aS,3'aS,8aR,8'aR)-2,2'-(1-Methylethylidene)bis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole, (3R,5R)-3-(Boc-amino)-5-fluoropiperidine, (3S)-1-[(Benzyloxy)carbonyl]-3-methyl-3-pyrrolidinecarboxylic acid, (3S,5S)-3-Amino-5-fluoro-piperidine-1-carboxylic acid tert-butyl ester, 4-[5-bis(3,5-ditert-butyl-4-methoxyphenyl)phosphanyl-1,3-benzodioxol-4-yl]-1,3-benzodioxol-5-yl]-bis, 4-bromo-1,1,2,2-tetrafluorobutane(SALTDATA: FREE), (4,7,10-TRI-BOC-1,4,7,10-TETRAAZACYCLODECAN-1-YL)ACETIC ACID, (4,7,10-TRIS-BENZYLOXYCARBONYLMETHYL-1,4,7,10TETRAAZA-CYCLODODEC-1-YL)-ACETIC ACID, (4S,4'S)-2,2'-methylenebis[4,5-dihydro-4-(phenylmethyl)-Oxazole, 5-BroMo-4,4,5,5-tetrafluoro-1-pentanol, 5,10,15,20-TETRAKIS(4-AMINOPHENYL)-21H,23H-PORPHINE, 5,10,15,20-TETRAKIS(4-HYDROXYPHENYL)-21H,23H-PORPHINE, 5,10,15,20-Tetrakis(4-nitrophenyl)porphyrin, 5,5,5-trifluoro-4-hydroxy-4-(trifluoromethyl)pentan-2-one, 7-Boc-3-oxa-7,9-diazabicyclo[3.3.1]nonane, 7-methoxy-7-oxoheptanoic acid, 7-(((S)-1-((2S,4R)-4-Hydroxy-2-(((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidin-1-, 9-Azabicyclo[3.3.1]nonane N-oxyl, Benzylidene-bis(tricyclohexylphosphine)dichlororuthenium, Bis(2-Methylindenyl)zirconiuM dichloride, Bis(acetonitrile)dichloropalladium(II), Chloro(1-naphthyl)bis(triphenylphosphine)nickel(II), D-Proline, 3-fluoro-, methyl ester, hydrochloride (1:1), di-tert-butyl 2,2'-(1,4,7,10-tetraazacyclododecane-1,4-diyl)diacetate, Dichloro(p-cymene)ruthenium(II) dimer, Diethyldicyclopentadiene,mixture of isomers, Dimethylsilylene (teramethylcyclopentadienyl)(indenyl) zirconium dichloride, DO3A tert-Butyl ester, (E)-N-(1-(mesitylimino)-3-methylbutan-2-yl)-2,4,6-trimethylaniline, Fmoc-cis-4-fluoro-Pro-OH, L-Proline, 3-fluoro-, methyl ester, hydrochloride (1:1), meso-Tetra(4-carboxyphenyl)porphine, N-[3,5-bis(trifluoroMethyl)phenyl]-N'-[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]-Thiourea, N-BOC-cis-4-fluoro-L-proline, N-(tert-Butoxycarbonyl)-(3S)-hydroxy-L-proline methyl ester, N-tert-Butyl-1,1-dimethyl-1-(2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl), N,N'-bis(2,4,6-trimethylphenyl)ethane-1,2-diimine, N,N'-Bis(2,4,6-trimethylphenyl)ethylenediamine, N,N'-Bis(2,6-diisopropylphenyl)-1,2-diimine, N,N-Bis(2,6-diisopropylphenyl)ethylenediamine, N,N,N',N'-tetramethylbenzene-1,3-diamine, O1-tert-butyl O2-methyl (2R,3S)-3-fluoropyrrolidine-1,2-dicarboxylate, Palladium(0) bis(dibenzylideneacetone), Pentanoic acid,5-bromo-4,4,5,5-tetrafluoro-, [(Phenylsulfonyl)amino]acetic acid, Potassium tetrahydrofuran-3-trifluoroborate, (R)-(+)-2-[2-(DIPHENYLPHOSPHINO)PHENYL]-4-(1-METHYLETHYL)-4,5-DIHYDROOXAZOLE, (R)-(+)-2,2'-Bis[di(3,5-dimethoxyphenyl)phosphino]-6,6'-dimethoxy-1,1'-biphenyl, (R)-(+)-2,2'-Bis(diphenylphosphino)-1,1'-binaphthyl, (R)-1-[(1S)-2-(DIPHENYLPHOSPHINO)FERROCENYL]ETHYLDI-TERT-BUTYLPHOSPHINE, (R)-3,3-difluoropyrrolidine-2-carboxylic acid, rel-1-(1,1-Dimethylethyl) 2-methyl (2R,3S)-3-fluoro-1,2-pyrrolidinedicarboxylate, RuCl(p-cymene)[(R,R)-Ts-DPEN, (S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethanamine, (S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethanamine hydrochloride, (S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethan-1-aminehydrochloride, (S)-2,2'-Bis(diphenylphosphino)-1,1'-binaphthalene, (S)-3,3-difluoropyrrolidine-2-carboxylic acid, (S)-4,4-Difluoropyrrolidine-2-carboxamide hydrochloride, (S)-(6,6′-Dimethoxybiphenyl-2,2′-diyl)bis[bis(4-methylphenyl)phosphine], (S,S)-N-(2-Amino-1,2-diphenylethyl)-p-toluenesulfonamide]chloro(p-cymene)ruthenium(II), (S,S)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminochromium(III) chloride, tert-butyl 2-(1,4,7,10-tetrazacyclododec-1-yl)acetate, tert-butyl (5R)-5-amino-3,3-difluoropiperidine-1-carboxylate, tert-butyl ((S)-1-((2S,4R)-4-hydroxy-2-(((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrro, tert-Butyl3,3-difluoro-5-oxopiperidine-1-carboxylate, Tetrakis(triphenylphosphite)nickel(0), Tri-tert-butyl 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetate, Tri-tert-butylphosphonium tetrafluoroborate, Yttrium(III) chloride hexahydrate
- Servicios de contratación y externalización: Custom Synthesis
- Pharma Chemicals: Fluorine compounds, Fluorinated building blocks, Biomedical intermediates
Nuestros Productos & Servicios
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Calificaciones
(0)
(0)
(0)
(0)
(0)
Comentarios
Filtros:
Ordenar por:
No hay comentarios disponibles.
Deja tu valoración & comentario